# Prantae

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prantae

- Industry: Software
- Headquarters: Odisha, India
- Website: www.prantae.solutions
- Total disclosed funding: $0.3M
- Latest round: Series A (Jan 15, 2025)
- Investors on record: 1

## About

Founded in 2015 by co-founders Sumona Karjee Mishra, Aseem Mishra, and Neel Ratan Guria and based in Odisha, India, Proflo-U, doing business as Prantae, provides advanced diagnostic devices, connected ecosystems, and precision reagents for improved patient care and monitoring. In January 2025, Prantae raised INR 50 million in seed funding led by investor Indian Angel Network. 

The company specialises in the development of innovative medical devices and in vitro diagnostic solutions tailored to address the rising challenge of non-communicable diseases. The flagship products include Proflo-U, a kidney monitoring system for measuring albumin, creatinine, and ACR, alongside EyeRa Pro-OS, a modular biomarker detection system using optical and electric sensing technologies. These products facilitate throughput sample handling and real-time monitoring in clinical biochemistry settings without requiring internet connectivity. Moreover, Prantae offers a proprietary diagnostic ecosystem with a range of COVID-19 diagnostic kits, including the ICMR-approved Embargo for viral RNA isolation and antibody detection, targeting healthcare professionals, laboratories, and research institutions in India.

Prantae Solutions generates revenue through B2B sales of its products and diagnostic kits to healthcare facilities, laboratories, and clinical research organisations.

The company will use the January 2025 funding to accelerate the development of advanced diagnostic solutions for kidney health and diabetes care, with a focus on research and development.

## Funding rounds

- Series A, Jan 15, 2025, $0.3M — Indian Angel Network

## Investors

- Indian Angel Network (https://capitalatlas.ai/funds/indian-angel-network) — Series A